High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season

Vaccine

Volumn 31, Issue 6, 2013, Pages 861-866

  DiazGranados, Carlos A ^a   Dunning, Andrew J ^a   Jordanov, Emilia ^a   Landolfi, Victoria ^a   Denis, Martine ^a   Talbot, H Keipp ^b  

^a SANOFI PASTEUR   (France)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aged; Aged, 80 and over; Clinical trial, phase III; Influenza vaccines, human; Vaccines, inactivated

Indexed keywords

HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; TRIPLE VACCINE;

AGED; ANTIBODY TITER; ARTICLE; BREAST DISEASE; CLINICAL ASSESSMENT; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CYST; DISEASE SURVEILLANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EAR DISEASE; EYE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEMAGGLUTINATION INHIBITION; HEPATOBILIARY DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPATHOLOGY; INFECTION; INFESTATION; INFLUENZA A (H1N1); INJURY; INNER EAR DISEASE; KIDNEY DISEASE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; POLYP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE TOXICITY; RESPIRATORY TRACT DISEASE; SKIN DISEASE; THORAX DISEASE; THORAX PAIN; UROGENITAL TRACT DISEASE; VACCINATION; VASCULAR DISEASE; VIRUS STRAIN;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; UNITED STATES;

EID: 84872598906     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.013     Document Type: Article

References (16)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(11):1333-1340.
3. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010, 59(RR-8):1-62.
4. Palache A. Seasonal influenza vaccine provision in 157 countries (2004-2009) and the potential influence of national public health policies. Vaccine 2011, 29(51):9459-9466.
5. Takayama M., Wetmore C.M., Mokdad A.H. Characteristics associated with the uptake of influenza vaccination among adults in the United States. Prev Med 2012, 54(5):358-362.
6. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. Adv Intern Med 1995, 123:518-527.
7. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272(21):661-665.
8. Praditsuwan R., Assantachai P., Wasi C., Puthavatana P., Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005, 88(2):256-264.
9. Couch R.B., Keitel W.A., Cate T.R. Improvement of inactivated influenza virus vaccines. J Infect Dis 1997, 176(Suppl. 1):S38-S44.
10. Falsey A., Treanor J.J., Tornieporth N., Capellan J. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. J Infect Dis 2009, 200:172-180.
11. Wood J.M., Gaines-Das R.E., Taylor J., Chakraverty P. Comparison of influenza serological techniques by international collaborative study. Vaccine 1994, 12(2):167-174.
12. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998, 17:857-872.
13. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998, 17:873-890.
14. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325(5937):197-201.
15. Jefferson T., Di Pietrantonj C., Rivetti A., Bawazeer G.A., Al-Ansary L.A., Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010, 7:CD001269.
16. Keitel W.A., Atmar R.L., Nino D., Cate T.R., Couch R.B. Increasing doses of an inactivated influenza A/H1N1 induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants. J Infect Dis 2008, 198:1016-1018.